- Home
- SURG vs PMN Comparison
SURG vs PMN Comparison
Compare SURG & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- PMN
- Stock Information
- Founded
- SURG 2006
- PMN 2004
- Country
- SURG United States
- PMN Canada
- Employees
- SURG N/A
- PMN N/A
- Industry
- SURG Advertising
- PMN Pharmaceuticals and Biotechnology
- Sector
- SURG Consumer Discretionary
- PMN Health Care
- Exchange
- SURG Nasdaq
- PMN Nasdaq
- Market Cap
- SURG 56.5M
- PMN 17.0M
- IPO Year
- SURG N/A
- PMN N/A
- Fundamental
- Price
- SURG $3.24
- PMN $0.45
- Analyst Decision
- SURG Strong Buy
- PMN Strong Buy
- Analyst Count
- SURG 1
- PMN 2
- Target Price
- SURG $9.00
- PMN $4.50
- AVG Volume (30 Days)
- SURG 106.8K
- PMN 49.4K
- Earning Date
- SURG 08-12-2025
- PMN 08-07-2025
- Dividend Yield
- SURG N/A
- PMN N/A
- EPS Growth
- SURG N/A
- PMN N/A
- EPS
- SURG N/A
- PMN N/A
- Revenue
- SURG $40,029,467.00
- PMN N/A
- Revenue This Year
- SURG $57.76
- PMN N/A
- Revenue Next Year
- SURG $112.61
- PMN N/A
- P/E Ratio
- SURG N/A
- PMN N/A
- Revenue Growth
- SURG N/A
- PMN N/A
- 52 Week Low
- SURG $1.05
- PMN $0.43
- 52 Week High
- SURG $3.47
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- SURG 61.40
- PMN 38.45
- Support Level
- SURG $2.86
- PMN $0.48
- Resistance Level
- SURG $3.31
- PMN $0.50
- Average True Range (ATR)
- SURG 0.24
- PMN 0.03
- MACD
- SURG 0.04
- PMN -0.00
- Stochastic Oscillator
- SURG 80.49
- PMN 15.44
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.